Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
NCT ID:
NCT02050412
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent
* Male or female between 18 years to 65 years
* A positive clinical history with inhalant allergy presumably due to cat allergen.
* Positive screening prick test (mean wheal diameter ≥ 3 mm) when tested with already standardized cat allergen extract.
* Positive screening prick test (wheal diameter ≥ 3mm) to Histamine dihydrochloride 10mg/ml.
Exclusion Criteria:
* Impaired in understanding the nature, meaning and scope of the study or incapable of giving written informed consent,
* Participation in another clinical trial within the last 30 days and during the present study,
* Pregnant or lactating women,
* Positive skin reaction in the screening prick test to negative control,
* Currently suffering from allergy symptoms,
* History of systemic reactions to allergens,
* Severe diseases influencing the results of the present study by discretion of the investigator,
* Immunotherapy with the allergen preparation during the past two years,
* Skin lesions and excessive hair-growth in the skin test areas,
* Treatment with prohibited concomitant medications according to section 9.3 (protocol) with the exception of medications with local effects which will not influence the results of the skin tests,
* Alcohol or drug abuse.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02050412
Study Brief:
Protocol Section:
NCT02050412